Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemozoin biocrystallization is a critical biological process in malaria parasites where toxic heme released from hemoglobin digestion is detoxified by conversion into an insoluble crystalline pigment called hemozoin. This process occurs within the parasite's digestive vacuole during its intraerythrocytic stage. Inhibition of this process is a validated antimalarial drug target.
Inhibition of hemozoin biocrystallization, leading to accumulation of toxic free heme within the parasite.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemozoin Biocrystallization (N/A).